Topline GLP-1 diabetes and weight loss medications like Ozempic, Wegovy and Saxenda are being investigated by the European Union for causing suicidal thoughts, and while drug manufacturer Novo Nordisk denies a connection between suicide and its drugs, some studies and case reports suggest there could be a potential link
Almost one-third of people in the U.S
Semaglutide (Wegovy): Pre-filled single-dose pens available in 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg
Recent prescribing patterns underscore this trend
Paid influencers are bound by the same rules regarding accurate and safe promotion of drugs, but the FDA has largely turned a blind eye to them, too
Semaglutide for weight loss is commonly given as a once-weekly subcutaneous injection when prescribed by a qualified medical provider